CATALOGO DEI PRODOTTI DELLA RICERCA

MELOTTI, Paola Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.018
NA - Nord America 4.937
AS - Asia 3.767
SA - Sud America 526
AF - Africa 85
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.800
RU - Federazione Russa 1.891
SG - Singapore 1.369
CN - Cina 1.233
GB - Regno Unito 1.134
IT - Italia 513
VN - Vietnam 418
BR - Brasile 415
SE - Svezia 292
DE - Germania 288
HK - Hong Kong 247
FR - Francia 223
FI - Finlandia 204
IE - Irlanda 204
KR - Corea 116
CA - Canada 93
IN - India 63
TR - Turchia 59
JP - Giappone 48
UA - Ucraina 45
ID - Indonesia 42
ES - Italia 34
NL - Olanda 34
PL - Polonia 34
AR - Argentina 32
IQ - Iraq 32
BE - Belgio 29
MX - Messico 26
AT - Austria 25
BD - Bangladesh 21
NG - Nigeria 20
CO - Colombia 17
EC - Ecuador 17
UZ - Uzbekistan 16
ZA - Sudafrica 16
PK - Pakistan 15
AU - Australia 12
VE - Venezuela 12
IR - Iran 11
PY - Paraguay 11
PE - Perù 9
CH - Svizzera 8
CL - Cile 8
CZ - Repubblica Ceca 8
LT - Lituania 8
PH - Filippine 8
AL - Albania 7
BJ - Benin 7
IL - Israele 7
NZ - Nuova Zelanda 7
SA - Arabia Saudita 7
TG - Togo 7
EG - Egitto 6
DO - Repubblica Dominicana 5
JO - Giordania 5
LV - Lettonia 5
MA - Marocco 5
MY - Malesia 5
NP - Nepal 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
KE - Kenya 4
KG - Kirghizistan 4
PT - Portogallo 4
CY - Cipro 3
GE - Georgia 3
GR - Grecia 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
NO - Norvegia 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RO - Romania 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
Totale 14.334
Salva come PNG Salva come JPEG
Città #
Southend 964
Singapore 717
Moscow 650
Chandler 581
Ashburn 511
San Jose 489
Dallas 392
Jacksonville 291
Woodbridge 289
Verona 254
Hong Kong 244
Ann Arbor 220
Beijing 211
Dublin 199
Houston 153
New York 146
The Dalles 113
Ho Chi Minh City 111
Munich 98
Jinan 91
Los Angeles 89
Wilmington 83
Princeton 72
Lawrence 71
Nanjing 71
Shenyang 70
Hanoi 66
Dong Ket 61
Helsinki 53
Tianjin 47
Turku 45
Santa Clara 41
Tokyo 37
Buffalo 35
Hebei 35
Seoul 35
São Paulo 35
Guangzhou 34
Montreal 34
Nanchang 33
Redondo Beach 33
Ningbo 31
Orem 31
Council Bluffs 30
Haikou 30
Jakarta 29
Brussels 28
Zhengzhou 27
Changsha 26
Lancaster 26
London 26
Milan 26
Hangzhou 24
Jiaxing 24
Taiyuan 24
Toronto 24
Warsaw 24
Chennai 23
Frankfurt am Main 23
Sindelfingen 23
Taizhou 23
Stockholm 22
Da Nang 21
Seattle 21
San Francisco 20
Vienna 20
Abuja 19
Brooklyn 19
Columbus 18
Fairfield 18
Madrid 18
Rome 18
Amsterdam 17
Falls Church 17
Phoenix 17
Boardman 16
Boston 15
Poplar 15
Tashkent 15
Barnet 14
Nuremberg 14
Lappeenranta 13
Rio de Janeiro 13
Atlanta 12
Belo Horizonte 12
Bologna 12
Chicago 12
Haiphong 12
Paris 12
Washington 12
Elora 11
Johannesburg 11
Norwalk 11
Istanbul 10
Redwood City 10
Brasília 9
Curitiba 9
Denver 9
Kent 9
Manchester 9
Totale 8.888
Salva come PNG Salva come JPEG
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 368
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 294
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 281
Detection of CFTR protein in human leukocytes by flow cytometry. 281
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 264
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 258
Analysis of CFTR function in human monocytes 255
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 253
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 251
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 231
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 229
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 228
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 228
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 224
Combining standardized and new CFTR functional tests for diagnosis 219
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 217
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 216
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 211
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 206
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 203
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 200
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 199
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 198
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 196
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 194
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 192
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 191
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 191
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 191
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 191
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 190
In vivo monitoring of lung inflammation in CFTR-deficient mice 189
20 In vivo monitoring of lung inflammation in CFTR–/– mice 185
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 183
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 182
Poster Session Abstracts 182
New clinical diagnostic procedures for cystic fibrosis in Europe. 180
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 172
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 168
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 167
Poster Session Abstracts 166
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 166
Poster Session Abstracts 165
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 163
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 160
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 160
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 159
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 159
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 157
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 156
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 156
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 156
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 155
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 151
Poster Session Abstracts 149
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 148
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 147
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 144
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 143
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 142
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 140
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 139
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 137
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 135
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 133
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 133
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 132
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 126
Oxidative stress and antioxidant therapy in cystic fibrosis 124
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 119
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 117
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 116
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 115
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 114
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 114
Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids 113
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers 112
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 112
RELEVANCE OF HLA-G IN CF 108
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 99
The role of macrophages and their scavenger receptors in cystic fibrosis 98
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 83
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 70
Comparison of Preclinical Drug Efficacy in Nasal and Intestinal Patient-Derived Models of Cystic Fibrosis 25
Drug Responsiveness in Patient-Derived Rectal Organoids Correlates with Clinical Response in CF Subjects: A Real-Life Analysis 14
Totale 14.488
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.505
article - articoli 24.656
book - libri 0
conference - conferenze 20.849
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.010
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 0 0 0 0 2 81 100
2021/2022741 88 241 4 43 45 19 8 28 27 28 52 158
2022/20231.472 113 175 109 267 115 359 17 79 171 8 40 19
2023/2024824 52 57 51 82 79 158 33 54 37 45 126 50
2024/20252.178 98 126 82 370 80 80 177 74 308 153 245 385
2025/20266.112 404 316 412 1.023 1.654 441 540 398 544 380 0 0
Totale 14.488